McGowen, A., Paraggio, N. A., Sobel, A. E., Kirwan, S. M., Shelburne, C. P., Pizzo, S. V., … Staats, H. F. (2007). The mast cell activator Compound 48/80 is a potent adjuvant for intradermally-administered anthrax protective antigen. JOURNAL OF IMMUNOLOGY, 178.

McGowen, Afton, Nicole A. Paraggio, Ashley E. Sobel, Shaun M. Kirwan, Chris P. Shelburne, Salvatore V. Pizzo, Soman N. Abraham, and Herman F. Staats. “The mast cell activator Compound 48/80 is a potent adjuvant for intradermally-administered anthrax protective antigen.” JOURNAL OF IMMUNOLOGY 178 (April 1, 2007).

McGowen A, Paraggio NA, Sobel AE, Kirwan SM, Shelburne CP, Pizzo SV, et al. The mast cell activator Compound 48/80 is a potent adjuvant for intradermally-administered anthrax protective antigen. JOURNAL OF IMMUNOLOGY. 2007 Apr 1;178.

McGowen, Afton, et al. “The mast cell activator Compound 48/80 is a potent adjuvant for intradermally-administered anthrax protective antigen.” JOURNAL OF IMMUNOLOGY, vol. 178, AMER ASSOC IMMUNOLOGISTS, Apr. 2007.

McGowen A, Paraggio NA, Sobel AE, Kirwan SM, Shelburne CP, Pizzo SV, Abraham SN, Staats HF. The mast cell activator Compound 48/80 is a potent adjuvant for intradermally-administered anthrax protective antigen. JOURNAL OF IMMUNOLOGY. AMER ASSOC IMMUNOLOGISTS; 2007 Apr 1;178.